Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Short-Term Debt issuances (2024)

bioAffinity Technologies (BIAF) has disclosed Short-Term Debt issuances for 1 consecutive years, with -$96911.0 as the latest value for Q4 2024.

  • Quarterly Short-Term Debt issuances changed N/A to -$96911.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $191849.0 through Dec 2024, changed N/A year-over-year, with the annual reading at -$45375.0 for FY2025, 123.65% down from the prior year.
  • Short-Term Debt issuances for Q4 2024 was -$96911.0 at bioAffinity Technologies, down from $261888.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $261888.0 in Q3 2024, with the low at -$96911.0 in Q4 2024.